Finnish biotech startup closed the seed round with €10M
Finland-based biotech company Onego Bio announces that it has raised 10 million euros during its last seed round. The company is creating an alternative to egg white in terms of meeting the needs of protein consumption rather than getting it directly from animals. To do this, it benefits from Trichoderma technology to produce bioalbumen with cellular agriculture tools which make it possible to have an animal-free alternative for egg consumption.